Table 2 Preoperative data
From: Is age an independent determinant of mortality in cardiac surgery as suggested by the EuroSCORE?
Age group | < 60 | 61–65 | 66–70 | 71–75 | 76–80 | 81–85 | 86–90 | p value |
|---|---|---|---|---|---|---|---|---|
n | 2180 | 1539 | 1798 | 1731 | 1169 | 293 | 58 | --- |
Female | 15,6% | 22,2% | 27,0% | 38,1% | 45,9% | 59,7% | 56,9% | < 0,005 |
COPD | 2,8% | 3,8% | 4,6% | 5.0% | 5,3% | 7,2% | 8,6% | < 0,005 |
Extracardiac arteriopathy | 10,6% | 15,7% | 17,7% | 19,2% | 18,8% | 15,7% | 20,7% | < 0,005 |
Neurological dysfunction | 2,6% | 3,0% | 4,7% | 4,3% | 4,0% | 5,5% | 1,7% | 0,006 |
Previous cardiac surgery | 4,8% | 4,8% | 5,6% | 4,6% | 4,4% | 3,1% | 5,2% | 0,658 |
Serum creatinine > 200 μmol/l | 1,6% | 1,6% | 1,2% | 2,5% | 1,8% | 0,7% | 5,2% | 0,038 |
Active endocarditis | 1,2% | 0,5% | 0,3% | 0,7% | 0,3% | 0,7% | 1,7% | 0,014 |
Critical preoperative state | 0,8% | 0,5% | 0,6% | 0,7% | 0,4% | 1,0% | 1,7% | 0,777 |
Unstable angina | 9,4% | 10,7% | 11,2% | 9,4% | 11,8% | 14,0% | 27,0% | < 0,005 |
LV ejection fraction 30–50% | 28,4% | 28,0% | 33,0% | 34,4% | 33,5% | 37,2% | 53,4% | < 0,005 |
LV ejection fraction < 30% | 4,3% | 4,8% | 5,6% | 4,7% | 5,5% | 4,4% | 6,9% | 0,635 |
Recent myocardial infarct | 11,1% | 9,4% | 9,9% | 9,5% | 7,4% | 9,2% | 3,4% | 0,034 |
Pulmonary hypertension | 5,1% | 4,5% | 4,5% | 6,4% | 6.0% | 8,5% | 6,9% | 0,032 |
Emergency | 1,4% | 1,3% | 1,1% | 1,7% | 1,5% | 1,7% | 5,2% | 0,309 |
Other than isolated CABG | 15,0% | 11,4% | 10,4% | 12,4% | 15,0% | 23,5% | 24,1% | < 0,005 |
Surgery on thoracic aorta | 2,6% | 1,2% | 1,0% | 1,2% | 0,5% | 0,7% | 0,0% | < 0,005 |
Postinfarction septal rupture | 0,0% | 0,1% | 0,0% | 0,0% | 0,0% | 0,0% | 0,0% | 0,157 |
Arterial hypertension | 62,2% | 70,1% | 74,0% | 74,6% | 71,7% | 67,2% | 100% | < 0,005 |
Diabetes mellitus | 20,1% | 27,6% | 28,8% | 29,6% | 29,9% | 27,6% | 17,2% | < 0,005 |
Atrial fibrillation | 2,9% | 4,8% | 6,1% | 9,5% | 9,8% | 14,7% | 13,8% | < 0,005 |